A method of preventing weakness in a patient with Parkinson's disease or of improving or restoring muscle strength of a patient with Parkinson's disease, comprising the step of administering to said patient an amount of one or more hepatocyte growth factor mimics sufficient to prevent, improve or restore to normal said muscle strength, said one or more hepatocyte growth factor mimics having a general structural formula 1 2 3 where R] is one of an N-acyl group, a substituted or unsubstiruted phenyl, a norleucine group, and an amino acid selected from tyrosine, phenylalanine, aspartic acid, arginine, isoleucine, serine, histidine, glycine, cysteine, methionine, tryptophan, lysine norvaline, ornithine, and s-benzyl cysteine
Curr Pharm Des 21:14041412 Brunst KJ, Baccarelli AA, Wright RJ (2015) Integrating mitochondriomics in childrens environmental health
A study with 6 participants (3 per group) is considered a pilot study it demonstrates that a concept is worth investigating further, but cannot prove that a treatment works
Most who take it for obesity or diabetes experience robust results while on the drug
Carlson et al., 2006
.png)
